Stanford Neuroscience Health Center

Clinical research site in Palo Alto, California

As of July 2026, 8 paid clinical trials are recruiting at Stanford Neuroscience Health Center in Palo Alto, California. Active studies at this site cover conditions such as Alzheimer's Disease, Amyloid and Becker Muscular Dystrophy. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at Stanford Neuroscience Health Center (8)

A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)

for Cognitive Dysfunction

42 locations incl. Chandler

Sponsor: Eli Lilly and Company

Sex: All·Age: 55 - 85

Code: NCT07589595·Phase 2·Recruiting·Listed May 2026

Apply to this trial

A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease

for Parkinsons Disease (PD)

33 locations incl. Sun City

Sponsor: BlueRock Therapeutics

Sex: All·Age: 45 - 75

Code: NCT06944522·Phase 3·Recruiting·Listed Apr 2025

Apply to this trial

A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)

for Alzheimer's Disease

26 locations incl. Fullerton

Sponsor: Bristol-Myers Squibb

Sex: All·Age: 60 - 85

Code: NCT06976203·Phase 3·Recruiting·Listed May 2025

Apply to this trial

A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

for Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

16 locations incl. Scottsdale

Sponsor: Takeda

Sex: All·Age: 18+

Code: NCT06747351·Phase 3·Recruiting·Listed Dec 2024

Apply to this trial

A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases

for Chronic Inflammatory Demyelinating Polyneuropathy

4 locations incl. Palo Alto

Sponsor: Kite, A Gilead Company

Sex: All·Age: 18 - 75

Code: NCT07304154·Phase 1·Recruiting·Listed Dec 2025

Apply to this trial

A Study to Evaluate Safety, Tolerability, and Efficacy of AB-1009 Gene Therapy (GAA Gene) in Adult Participants With Late Onset Pompe Disease (PROGRESS-GT LOPD)

for Pompe Disease (Late-onset)

9 locations incl. Phoenix

Sponsor: AskBio Inc

Sex: All·Age: 18+

Code: NCT07282847·Phase 1, Phase 2·Recruiting·Listed Dec 2025

Apply to this trial

A Study to Learn How Nusinersen (Spinraza) Affects Participants With Spinal Muscular Atrophy (SMA) Who Took it Before or During Pregnancy And About The Health of Their Babies

for Muscular Atrophy, Spinal

3 locations incl. Palo Alto

Sponsor: Biogen

Sex: Female·Age: 18 - 54

Code: NCT05789758·Recruiting·Listed Mar 2023

Apply to this trial

Safety and Preliminary Efficacy of ULSC in Facioscapulohumeral Muscular Dystrophy (FSHD)

for FSHD - Facioscapulohumeral Muscular Dystrophy

1 location in Palo Alto

Sponsor: Restem, LLC.

Sex: All·Age: 15+

Code: NCT07086521·Phase 1·Recruiting·Listed Jul 2025

Apply to this trial

More research sites in Palo Alto

Stanford University (162 trials)
Stanford Cancer Institute Palo Alto (35 trials)
Stanford University Medical Center (29 trials)
Lucile Packard Children's Hospital (27 trials)
VA Palo Alto Health Care System, Palo Alto, CA (25 trials)
Lucile Packard Children's Hospital Stanford University (23 trials)
Stanford University School of Medicine (21 trials)
VA Palo Alto Health Care System (21 trials)
Stanford Cancer Center (21 trials)
Stanford Cancer Institute (19 trials)

Explore more

Paid clinical trials in Palo Alto, CA · California clinical trials